Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Single-cell transcriptome profiling of tumour tissue isolates allows the characterization of heterogeneous tumour cells along with neighbouring stromal and immune cells. Here we adopt this powerful approach to breast cancer and analyse 515 cells from 11 patients. Inferred copy number variations from the single-cell RNA-seq data separate carcinoma cells from non-cancer cells. At a single-cell resolution, carcinoma cells display common signatures within the tumour as well as intratumoral heterogeneity regarding breast cancer subtype and crucial cancer-related pathways. Most of the non-cancer cells are immune cells, with three distinct clusters of T lymphocytes, B lymphocytes and macrophages. T lymphocytes and macrophages both display immunosuppressive characteristics: T cells with a regulatory or an exhausted phenotype and macrophages with an M2 phenotype. These results illustrate that the breast cancer transcriptome has a wide range of intratumoral heterogeneity, which is shaped by the tumour cells and immune cells in the surrounding microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Limited T-cell recruitment and function in the TME correlates with poor prognosis in BC (21,22).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · cited 1×
“4.0b (default parameters) 55 , and relative gene expression was quantified as transcript per million (TPM) using RSEM v1.”
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · cited 1×
“To assess gene expression signatures and pathway activation, a non-parametric and unsupervised software algorithm called GSVA software in the R package 58 with the RNA-seq mode was used.”
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · cited 1×
“To further delineate the identity of carcinoma and non-carcinoma cells, we analysed the expression of tumour-associated stromal or immune gene sets proposed in the tumour purity estimation, ESTIMATE 26 .”
Cited by
Items 601–700 of 999
Identification of non-cancer cells from cancer transcriptomic data
Bortolomeazzi, M., Keddar, M. R., Ciccarelli, F. D., & Benedetti, L. G. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.194445 · Cited by 10
Li, H., Huang, Y., Sharma, A., Ming, W., Luo, K., Gu, Z., Sun, X. S., & Liu, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.751530 · Cited by 9
“, and GSE75688) (20, 27), where the cellular proportions for each patient sample were known in advance, were used as realistic bulk gene expression data (by aggregating reads from all cell barcodes for each patient sample).”
MethodResultInfluentialData-Driven Modeling of Breast Cancer Tumors Using Boolean Networks
Sgariglia, D., Conforte, A. J., Pedreira, C. E., de Carvalho, L. A. V., Carneiro, F. R. G., Carels, N., & da Silva, F. A. B. (2021) · Frontiers in Big Data · doi:10.3389/fdata.2021.656395 · Cited by 10
Martini, P. G. V., Sales, G., Diamante, L., Perrera, V., Colantuono, C., Riccardo, S., Cacchiarelli, D., Romualdi, C., & Martello, G. (2022) · Communications Biology · doi:10.1038/s42003-022-03087-4 · Cited by 7
Li, L., Zhang, Y., Ren, Y., Cheng, Z., Zhang, Y., Wang, X., Zhao, H., & Lu, H. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.849798 · Cited by 8
“, 2016), GSE75688 (Chung et al., 2017), GSE84465 (Darmanis et al.”
Vidal, M., Fraga, M., Llerena, F., Vera, A., Hernández, M., Koch, E. S., Reyes‐López, F. E., Vallejos‐Vidal, E., Cabrera-Vives, G., & Nova‐Lamperti, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911065 · Cited by 8
“In this study, we analyzed publicly available scRNA-seq data from CD4-T, CD8-T and Treg cells isolated from melanoma [22,23], breast [24,25], lung [26,27], colorectal [28] and head and neck [29] cancer.”
MethodCD8+ T cell metabolic changes in breast cancer
Castoldi, Â., Lee, J., Carvalho, D. D. S., & Souto, F. O. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166565 · Cited by 12
Self-citationA Focus on the Synergy of Radiomics and RNA Sequencing in Breast Cancer
Bellini, D., Milan, M., Bordin, A., Rizzi, R., Rengo, M., Vicini, S., Onori, A., Carbone, I., & FALCO, E. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087214 · Cited by 8
Identification of marker genes and cell subtypes in castration-resistant prostate cancer cells
Lin, X., Lin, N., Lin, T., Wu, Y., Huang, P., Ke, Z., Lin, Y., Chen, S., Zheng, Q., Wei, Y., et al. (2021) · Journal of Cancer · doi:10.7150/jca.49409 · Cited by 10
“On the one hand, identification of marker genes through transcriptional data among individual cell is an excellent way to facilitate the understanding of tumor heterogeneity and clinical practice [16, 17].”
BackgroundJia, S., & Hu, P. (2021) · Genomics · doi:10.1016/j.ygeno.2021.04.037 · Cited by 12
IRF8 Governs Tumor-Associated Macrophage Control of T Cell ExhaustionPreprint
Nixon, B. G., Kuo, F., Liu, M., Capistrano, K. J., Do, M., Franklin, R. A., Wu, X., Kansler, E. R., Srivastava, R. M., Purohit, T. A., et al. (2020) · SSRN Electronic Journal · doi:10.1101/2020.03.12.989731 · Cited by 9
“In addition, the IRF8high group had significant enrichment for T cell checkpoint and exhaustion signatures (Chung et al., 2017) (Figure 7C and F).”
BackgroundThe clinical relevance of unfolded protein response signaling in breast cancerPreprint
Oshi, M., Roy, A. M., Gandhi, S., Tokumaru, Y., Yan, L., Yamada, A., Endo, I., & Takabe, K. (2022) · Research Square · doi:10.21203/rs.3.rs-1480002/v1 · Cited by 8
Inference of single-cell network using mutual information for scRNA-seq data analysis
Chang, L.-Y., Hao, T.-Y., Wang, W., & Lin, C. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05895-3 · Cited by 9
“…data and offers an attractive alternative to explore genetic and functional heterogeneity with cellular resolution via expression profiling studies; for example, the discovery of unidentified cell types [3], human embryonic development [4], and intra-and inter-tumoral heterogeneity [5, 6].”
BackgroundLaghaee, S., Eskandarian, M., Fereidoon, M., & Koohi, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40732 · Cited by 9
Arima, J., Chida, K., Wu, R., Taniguchi, K., McKenery, A., Morreale, B. G., Monell, A. M., Abrams, S. I., Ebos, J. M. L., Hakamada, K., et al. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-18260-2 · Cited by 7
“19 This approach allows for the characterization of (1) immune cell infiltration, (2) stromal cell interactions, and (3) transcriptional expression within the TME.”
Next-generation sequencing in breast cancer: current clinical applications and future directions
Zuhdi, N. F. M., Siddig, A., Nafi, S. N. M., Salleh, M. S. M., Yahya, M. M., Zain, W. Z. W., Din, T. A. D. A. T., & Rahman, W. F. W. A. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2569989 · Cited by 12
“Both T lymphocytes and macrophages exhibit immunosuppressive traits, with T cells demonstrating either a regulatory or exhausted phenotype and macrophages displaying an M2 phenotype [68].”
Koh, S., Dontchos, B. N., Bossuyt, V., Edmonds, C. E., Cristea, S., Melkonjan, N., Mortensen, L. J., Ma, A., Beyerlin, K., Denault, E. N., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00224-w · Cited by 8
Liao, N., Li, C., Cao, L., Chen, Y., Ren, C., Chen, X.-Q., Mok, H., Wen, L., Li, K., Wang, Y., et al. (2022) · Breast Cancer · doi:10.1007/s12282-022-01400-x · Cited by 7
Ning, L., & Xie, N. (2024) · Cancer Management and Research · doi:10.2147/cmar.s445248 · Cited by 7
Hsu, R. C., Al-Zubeidy, B., Flores, D., Nazarian, A., Baugh, A. G., Gonzalez, E. R., Castanon, S. L., Xiu, J., Kang, I. M., SPICER, D. V., et al. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07295-w · Cited by 8
“…to primary breast tumors revealed Extended author information available on the last page of the article greater immune-suppression with T-cell exhaustion, clonal expansion of regulatory T-cells (T-regs) and increased M2-like tumor associated macrophages (TAM) corelating with worse outcomes [11–13].”
BackgroundCanopy2: Tumor Phylogeny Inference by Bulk DNA and Single-Cell RNA Sequencing
Weideman, A. M., Wang, R., Ibrahim, J. G., & Jiang, Y. (2025) · Statistics in Biosciences · doi:10.1007/s12561-024-09466-1 · Cited by 8
“Canopy2 consistently assigned more cells to clones than the other two methods in samples from patients with breast cancer [59] and glioblastoma [60] (Fig.”
InfluentialWu, W. H., Wang, Z., Liu, L., Huang, J., Qiu, H., Peng, L., & Nie, L. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00726 · Cited by 7
Zhang, Y., Zhang, D., Meng, Q., Liu, Z., Xie, H., Liu, L., Xu, F., & Chen, X. (2021) · BMC Cancer · doi:10.1186/s12885-021-08617-7 · Cited by 9
Kannan, J., Mathews, L., Wu, Z., Young, N. S., & Gao, S. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04625-x · Cited by 8
“Both scSNV and scCNV play important roles in tumor generation and progression in cancer and contribute to tumor heterogeneity [2, 5, 11, 12].”
BackgroundMethodIdentification of immune cell function in breast cancer by integrating multiple single-cell data
Zhang, L., Qin, Q., Chen, X., Zhang, N., & Zhao, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1058239 · Cited by 7
Gene selection and clustering of single-cell data based on Fisher score and genetic algorithm
Feng, J., Zhang, J., Zhu, X., & Wang, J. (2022) · The Journal of Supercomputing · doi:10.1007/s11227-022-04920-7 · Cited by 7
Cao, C., Lu, X., Guo, X., Zhao, H., & Gao, Y. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113538 · Cited by 7
Changes in the immune landscape of TNBC after neoadjuvant chemotherapy: correlation with relapse
Moamin, M. R., Allen, R. J., Woods, S. L., Brown, J. E., Nunns, H., Juncker‐Jensen, A., & Lewis, C. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1291643 · Cited by 13
Mechanistic understanding of cellular responses to genomic stress
Hanawalt, P. C., & Sweasy, J. B. (2019) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22349 · Cited by 7
“This approach forms the basis for “precision oncology,” in which the unique genotype and transcriptome of cells from a tumor is ascertained prior to the design of an appropriate regimen of chemotherapy (Darmanis et al. 2015; Cheow et al. 2016; Chung et al. 2017).”
BackgroundPoirion, O., Zhu, X., Ching, T. H., & Garmire, L. X. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/095810 · Cited by 7
Dissecting the contributions of tumor heterogeneity on metastasis at single-cell resolutionPreprint
Winkler, J., Tan, W., Diadhiou, C. M. M., McGinnis, C. S., Abbasi, A. J., Hasnain, S., Durney, S., Atamaniuc, E., Superville, D. A., Awni, L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.04.502697 · Cited by 7
Self-citationMadan, S., Chang, T., Harris, A. R., Liu, H., Martinez, A., Dhruba, S. R., Wang, B., Rajagopal, P. S., Sinha, S., Srinivasan, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.19.644074 · Cited by 8
Determinants, mechanisms, and functional outcomes of myeloid cell diversity in cancer
Caronni, N., Montaldo, E., Mezzanzanica, L., Cilenti, F., Genua, M., & Ostuni, R. (2021) · Immunological Reviews · doi:10.1111/imr.12944 · Cited by 6
Skok, K., Macciò, U., Martin, S. D., & Bräutigam, K. (2025) · Cancer Medicine · doi:10.1002/cam4.71023 · Cited by 8
“In contrast, RNA sequencing—both bulk and single-cell—offers a high-resolution view of immune cell diversity and activation states, although these methods do not retain spatial information and can miss rare cell populations [88].”
Yuan, Z., Liu, Z., Zhou, M., Wen, H., & Li, B. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105111 · Cited by 6
Pan-cancer network disorders revealed by overall and local signaling entropy
Feng, L., Sun, Y., Li, C., Li, Y., Chen, L., & Zeng, R. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab031 · Cited by 6
“To validate this association, we next retrieved a singlecell sequencing dataset of breast cancer (GSE75688) (Chung et al., 2017) and observed that single cells from metastatic sites had higher entropy values than those from primary tumors (Supplementary Figure S2D).”
MethodShi, A., Yan, M., Pang, B., Pang, L., Wang, Y., Lan, Y., Zhang, X., Xu, J., Ping, Y., & Hu, J. R. (2023) · BMC Immunology · doi:10.1186/s12865-023-00587-8 · Cited by 8
“Furthermore, B cells with regulatory (Breg) phenotype could suppress antitumor immunity and facilitate tumor development by regulating different cell types including T cells and TAMs and associated with poor prognosis [7, 9].”
BackgroundInfluentialLiang, Y., Zhong, D., Yang, Q., Tang, Y., Qin, Y., Su, Y., Huang, X., & Shang, J. (2024) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s453249 · Cited by 8
“…and gain insight into the tumor biology, thereby resolving the expression patterns of unique cell populations and enabling studies of the relationship between unique subtypes and HCC. 11,12 The unique ecosystem of HCC tissue contains a variety of cell lines, including hepatocytes and immune cells.”
BackgroundAssessing transcriptomic heterogeneity of single-cell RNASeq data by bulk-level gene expression data
Tiong, K.-L., Luzhbin, D. A., & Yeang, C. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05825-3 · Cited by 7
“To answer this question, we employed backward deconvolution to one bulk-level breast cancer RNASeq dataset (METABRIC, [55]) and two single-cell RNASeq datasets (GSE75688, [56]; GSE176078, [57]), and focused on cancer cells in the two sc-RNASeq datasets.”
MethodXin, S., Zhang, Y., Zhang, Z., Li, Z., Sun, X., Liu, X., Jin, L., Li, W., Tang, C., Mei, W., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00779-3 · Cited by 8
Tiong, K.-L., Lin, Y., & Yeang, C. (2022) · Biology Open · doi:10.1242/bio.059256 · Cited by 10
“…in the present study Cancer type ID # patients # cancer cells # normal cells # valid genes Reference TCGA Breast cancer GSE75688 11 317 198 8318 Chung et al., 2017 BRCA Melanoma GSE72056 19 1174 2772 8119 Tirosh et al., 2016a SKCM Melanoma GSE81383 3 307 0 8097 Gerber et al., 2017 SKCM…”
BackgroundSingle-Cell Transcriptome Analysis of Treg
Tan, B. J. Y., Ono, M., & Satou, Y. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2647-4_17 · Cited by 6
SMURF: embedding single-cell RNA-seq data with matrix factorization preserving self-consistency
Pu, J., Wang, B., Liu, X., Chen, L., & Li, S. C. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad026 · Cited by 7
Wright, S., Burkholz, S., Zelinsky, C., Wittman, C., Carback, R. T., Harris, P. E., Blankenberg, T., Herst, C. V., & Rubsamen, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411827 · Cited by 8
“More recently developed RNA-Seq methods, such as spatial single-cell or subcellular RNA-Seq, will allow for a higher resolution understanding of survivin expression within tumor tissue [34].”
MethodChen, L., Ge, M., Mo, S., Shi, M., Zhang, J., & Liu, J. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673296767240116215814 · Cited by 12
RetractedLiu, S., Li, X. J., Zhang, Y., Deng, Y., Li, Z., Zhu, Y., Li, X., Shang, Y., Yang, G., Zhan, X., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33219 · Cited by 6
“The most referenced work was a 2017 paper by Chung et al. [18], entitled “ Single-cell RNA-seq enables comprehensive tumor and immune cell profiling in primary breast cancer ” published in Nature Communications .”
BAF complexes and the glucocorticoid receptor in breast cancers
Dietrich, N., Hoffman, J. A., & Archer, T. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.07.001 · Cited by 7
“For instance, scRNA-seq studies have demonstrated that heterogeneity in immune cell populations within tumors have expanded the diversity of breast cancer, demonstrating the contribution of immune cells to breast cancer phenotypes [49,50].”
BackgroundLan, T., Hutvágner, G., Lan, Q., Liu, T., & Li, J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa248 · Cited by 7
Xu, Y., Wang, J., Li, F., Zhang, C., Zheng, X., Cao, Y., Shang, D., Hu, C., Xu, Y., Mi, W., et al. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.01.022 · Cited by 6
“For example, approximately 20 percent of the ER + patients were insensitive to endocrine therapy or developed acquired drug resistance [52].”
BackgroundComprehensive analysis of immune evasion in breast cancer by single-cell RNA-seqPreprint
Yin, J., Li, Z., Yan, C., Fang, E., Wang, T., Zhou, H., Luo, W., Zhou, Q. X., Zhang, J., Hu, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/368605 · Cited by 6
Deep learning based deconvolution methods: A systematic review
Redondo, A. L., Velázquez, J. M. S., García-Tejedor, Á. J., & Lobo, V. J. S.-A. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.05.038 · Cited by 5
Saha, S., Mahapatra, S., Khanra, S., Mishra, B., Swain, B., Malhotra, D., Saha, S., Panda, V. K., Kumari, K., Jena, S., et al. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2025.69 · Cited by 27
(2025) · doi:10.1080/15476286.2025.2563860 · Cited by 5
“Single-cell RNA sequencing data from breast cancer patients (GSE75688) [17] were analysed to detect intronic transcripts.”
MiR-200c reprograms fibroblasts to recapitulate the phenotype of CAFs in breast cancer progression
Zhao, L., Roche, M. E., Diaz‐Barros, V., Domingo‐Vidal, M., Whitaker‐Menezes, D., Tuluc, M., Uppal, G. K., Caro, J., Curry, J., & Martinez‐Outschoorn, U. (2024) · Cell Stress · doi:10.15698/cst2024.03.293 · Cited by 8
“These findings were validated in another publicly available scRNASeq data of BRCA (E-GEOD-75688) [28] (SFig.”
Wang, W., Dong, G., Yang, Z., Li, S., Li, J., Wang, L., Zhu, Q., & Wang, Y. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12445 · Cited by 5
Tseng, T.-Y., Hsieh, C.-H., Liu, J., Huang, H., & Juan, H. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.04.030 · Cited by 6
“Recently, single-cell RNA-sequencing (scRNA-seq) has emerged as a powerful technology allowing gene expression profiling at single-cell resolution, providing unprecedented insights into the heterogeneity and complexity of tumor cell populations and underlying molecular mechanisms [7,8].”
Applications of single‐cell multi‐omics sequencing in deep understanding of brain diseases
Zhang, X., Lü, P., & Shen, X. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.95 · Cited by 6
Kvokačková, B., Fedr, R., Kužílková, D., Stuchlý, J., Vávrová, A., Navrátil, J., Fabián, P., Ondruššek, R., Ovesná, P., Remšík, J., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13365 · Cited by 6
Huang, M., Long, C., & Ma, J. (2023) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac047 · Cited by 6
Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer
Lei, J., Luo, J., Liu, Q., & Wang, X. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00886-7 · Cited by 5
“We also downloaded three single-cell RNA sequencing (scRNA-seq) datasets, namely GSE75688 for BRCA [29], GSE131309 for SARC [30], and GSE89567 for GBM [25], from the NCBI gene expression omnibus (GEO) (https:// www. ncbi . nlm . nih . gov/ geo/).”
Imputation method for single-cell RNA-seq data using neural topic model
Qi, Y., Han, S., Tang, L., & Liu, L. (2022) · GigaScience · doi:10.1093/gigascience/giad098 · Cited by 6
Clustering scRNA-seq data with the cross-view collaborative information fusion strategy
Lou, Z., Wei, X., Hu, Y., Hu, S., Wu, Y., & Tian, Z. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae511 · Cited by 7
scSFCL:Deep clustering of scRNA-seq data with subspace feature confidence learning
Meng, X., Zhang, Y., Xu, X., Zhang, K., & Feng, B. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108292 · Cited by 6
Bhise, K., Sau, S., Alzhrani, R. M., Rauf, M. A., Tatiparti, K., & Iyer, A. K. (2021) · Materials Today Advances · doi:10.1016/j.mtadv.2021.100138 · Cited by 6
Li, Z., Zhang, Q., Wang, P., Song, Y., & Wen, C. (2022) · Applied Intelligence · doi:10.1007/s10489-022-03657-3 · Cited by 6
New Drug Development and Clinical Trial Design by Applying Genomic Information Management
Ko, Y. K., & Gim, J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081539 · Cited by 5
“scRNA-seq has been applied in hepatocellular carcinoma [49], NSCLC [50], and primary breast cancer [48] and helps in the stratification and accurate classification of patients.”
MethodLiu, C., Pu, M., Ma, Y., Wang, C., Kong, L.-H., Zhang, S., Zhao, X., & Lian, X. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221110659 · Cited by 7
Gaussian kernel based gene selection in a single cell gene decision space
Li, Z., Feng, J., Zhang, J., Liu, F., Wang, P., & Wen, C. (2022) · Information Sciences · doi:10.1016/j.ins.2022.08.050 · Cited by 5
Ruan, Z., Chi, D., Wang, Q., Jiang, J., Quan, Q., Bei, J., & Peng, R. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5684 · Cited by 7
Sex-specific gene expression patterns in head and neck squamous cell carcinomas
Wang, S., Pan, W. D., Mi, W.-X., & Wang, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14890 · Cited by 8
A single-cell approach to engineer CD8+ T cells targeting cytomegalovirus
Wang, F., Xu, Q., Zhuang, Z., Li, Z., Gao, Q., Huang, Y., Luo, Y., Zhang, X., Zhu, L., & Chao, C. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0466-z · Cited by 5
Ravera, F., Cirmena, G., Dameri, M., Gallo, M., Vellone, V. G., Fregatti, P., Friedman, D., Calabrese, M., Ballestrero, A., Tagliafico, A. S., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-054256 · Cited by 6
Extensive exploration of T cell heterogeneity in cancers by single cell sequencing
Wang, X., & Li, Y. (2019) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2019.02.15 · Cited by 4
ClusterMine: A knowledge-integrated clustering approach based on expression profiles of gene sets
Li, H., Xu, Y., Zhu, X., Liu, Q., Omenn, G. S., & Wang, J. (2020) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720020400090 · Cited by 5
Roden, D. L., Baker, L. A., Elsworth, B., Chan, C., Harvey, K., Deng, N., Wu, S. Z., Cazet, A., Nair, R., & Swarbrick, A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/282079 · Cited by 5
“Recent single-cell studies in breast cancer have shown that transcriptional heterogeneity can be characterised using a number of different techniques and tumour cell types, such as: cell-lines; PDX models and primary clinical samples (Chung et al., 2017; Gao et al., 2017; Savage et al., 2017).”
BackgroundTorang, A., Gupta, P., & Klinke, D. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/623082 · Cited by 5
Gao, Y., Li, L., Amos, C. I., & Li, W. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.23.310649 · Cited by 5
“On the one hand, contrary to a previous single-cell APA analysis performed on aggregated “meta-genes” in the same breast cancer dataset (Chung et al. 2017), which showed that no differences in APA were associated with cancer subtypes or patients (Kim et al. 2019), we found that tumor cells were…”
BackgroundMethodResultMahin, K. F., Robiuddin, M., Islam, M., Ashraf, S., Yeasmin, F., & Shatabda, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.10.439266 · Cited by 5
“have collected samples of 22 types of cancer and from GEO, we have collected breast cancer (GSE75688) [24] and skin melanoma cancer (GSE72056) [25] samples.”
BackgroundDing, L., Shi, H., Qian, C., Burdyshaw, C., Veloso, J. P., Khatamian, A., Pan, Q., Dhungana, Y., Xie, Z., Risch, I., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.26.523391 · Cited by 5
Hypergraph representations of single-cell RNA sequencing data for improved cell clustering
He, W., Bolnick, D. I., Scarpino, S. V., & Eliassi‐Rad, T. (2026) · Bioinformatics · doi:10.1093/bioinformatics/btag148 · Cited by 6
“…and Arendt 2017), tissue heterogeneity analysis for cancer research (Karaayvaz et al. 2018, Laviron et al. 2022, Wong et al. 2022), immune cell profiling for therapy development (Ermann et al. 2015, Chung et al. 2017, Lyons et al. 2017, Landhuis 2018), and biomarker discovery for diagnosis.”
Ren, M., Ma, H., Guo, L., Liu, Y., Wang, L., & Wei, S. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10922-2 · Cited by 5
“We used the single-cell transcriptome profile to infer copy number variations (CNVs) of epithelial cells in different subtypes of GC using the R package inferCNV (Chung et al. 2017).”
Zhang, N., Liu, Q., Wang, Q., Liu, X., Zhang, S., Tian, X., Li, L., Wang, S., Lv, B., & Jiang, S. (2025) · Oncology Letters · doi:10.3892/ol.2025.14876 · Cited by 6
Cells-of-Origin of Breast Cancer and Intertumoral Heterogeneity
Joyce, R., & Visvader, J. E. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-70875-6_9 · Cited by 6
Host-microbe-cancer interactions on-a-chip
Sousa, M. G. C., Brasino, D. S. K., Krieger, M., Dindar, D. A., Duhen, R., Zhang, Z., França, C. M., & Bertassoni, L. E. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1505963 · Cited by 6
Bernal, A. M. C., Pham, V., Li, X., Liu, L., Li, J., & Le, T. D. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac030 · Cited by 4
“We applied our method to the single-cell RNA sequencing data from NCBI GEO database, accession GSE75688 [22].”
InfluentialZhang, Q., Zhao, Z., Liu, F., & Li, Z. (2023) · Applied Soft Computing · doi:10.1016/j.asoc.2023.110645 · Cited by 6
Rodríguez-Bejarano, O. H., Roa, L., Vargas-Hernández, G., Botero-Espinosa, L., Parra-López, C., & Patarroyo, M. A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189064 · Cited by 4
Single-cell biclustering for cell-specific transcriptomic perturbation detection in AD progression
Gong, Y., Xu, J., Wu, M., Gao, R., Sun, J., Yu, Z., & Zhang, Y. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100742 · Cited by 6
Uncovering Molecular and Genetic Drivers of Dental Caries Via scRNA-seq and Mendelian Randomisation
Wang, J., Zhou, Y., Xu, W., Li, Z., Guo, C., & Bian, Q. (2024) · International Dental Journal · doi:10.1016/j.identj.2024.10.005 · Cited by 6
Advancements in the Application of scRNA-Seq in Breast Research: A Review
Zhang, Z., Ma, X., La, Y., Guo, X., Chu, M., Bao, P., Yan, P., Wu, X., & Liang, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413706 · Cited by 7
Chen, N., Hua, R., Yang, Y., Liang, J., Liu, W., Wang, L., Yao, X., Li, A., Long, Y., Feng, R., et al. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03829-8 · Cited by 4
“Single-cell transcriptomic analyses of liver [6], pancreatic [7], breast [8], and lung cancer [9], have been performed and revealed the heterogeneity and complexity of these tumors.”
Zhao, J., Zhang, X., Wang, G., Lin, Y., Liu, T., Chang, R. B., & Zhao, H. (2026) · Nature Genetics · doi:10.1038/s41588-026-02579-x · Cited by 10
“28–30).”
A High Epigenetic Risk Score Shapes the Non-Inflamed Tumor Microenvironment in Breast Cancer
Zhang, D., Wang, Y., & Yang, Q. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.675198 · Cited by 8
“Nowadays, exploiting the intrinsic interplay of host immune system and malignant tumors has achieved impressive success (Chung et al., 2017; Plava et al., 2019).”
BackgroundHatil, A. C., Bicakci, G. K., Savaş, B., Dioken, D. N., Henden, Ş. O., Can, T., Karaca, E., & Erson-Bensan, A. E. (2021) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26284 · Cited by 6
“6 (Full-Length Isoform of EIF2Bγ) isoforms.(19) For visualization of reads, IGV was used.”
MethodJiang, H.-J., Huang, Y., & Li, Q. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac113 · Cited by 5
Ju, G., Zeng, K., Lu, L., Diao, H., Wang, H., Li, X., & Zhou, T. (2023) · PubMed Central · Cited by 4
FEED: a feature selection method based on gene expression decomposition for single cell clustering
Zhang, C., Duan, Z.-W., Xu, Y., Liu, J., & Li, H. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad389 · Cited by 4
Wang, S., An, J., Hu, X., Zeng, T., Li, P., Qin, J., Shen, Y., Chen, M., & Wen, F. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.15145 · Cited by 4
Satish, K. S., Saraswathy, G. R., Ritesh, G., Saravanan, K. S., Krishnan, A., Bhargava, J., Kuri, U., & Dsouza, P. L. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.05.002 · Cited by 5
In�vivo effects of mutant RHOA on tumor formation in an orthotopic inoculation model
Nishizawa, T., Nakano, K., Fujii, E., Komura, D., Kuroiwa, Y., Ishimaru, C., Monnai, M., Aburatani, H., Ishikawa, S., & Suzuki, M. (2019) · Oncology Reports · doi:10.3892/or.2019.7300 · Cited by 4
“Since several reports show detailed cross-talk between tumor and components of the tumor microenvironment (37-39), we anticipate that single cell RNA sequencing will more precisely reveal the interaction between the tumor and its microenvironment and the molecular mechanisms involved.”
Background
Metadata
- Authors
- Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., Kan, Z., Han, W., & Park, W.-Y.
- Affiliations
- Samsung Medical Center (KR)
- Seoul National University (KR)
- Pfizer (United States) (US)
- Corresponding author
- Han, Wonshik
- Park, Woong-Yang
- ORCID
- Venue
- Nature Communications
- Published
- 2017-05-05
- Volume
- 8
- Issue
- 1
- Pages
- 15081-15081
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5424158
- OpenAlex
- W2610509384
- Cited by
- 992
- References
- 62
- Citations by year
- 2026: 57 · 2025: 85 · 2024: 116 · 2023: 117 · 2022: 148 · 2021: 191 · 2020: 106 · 2019: 93 · 2018: 63 · 2017: 11
- FWCI
- 30.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- National Research Foundation of Korea (2015R1A2A2A01008264, 2016R1A5A1011974)
- Samsung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, intratumoral heterogeneity, tumor immune microenvironment, tumor stroma, T cells, B cells, macrophages, regulatory T cells, T cell exhaustion, M2 macrophages, tumor subtypes, tumor transcriptome, copy number variation
- MeSH terms
- Exome Sequencing, B-Lymphocytes, Breast Neoplasms, Female, Humans, Lymph Nodes, Macrophages, Receptors, Estrogen, Receptors, Progesterone, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Sequence Analysis, RNA, Carcinoma, Ductal, Breast, Erb-b2 Receptor Tyrosine Kinases, Receptor, ErbB-2, Gene Expression Profiling, DNA Copy Number Variations, Single-Cell Analysis, Tumor Microenvironment, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.